Return to search

IPO Profile: GlobeImmune Inc

Company Details

Location: 1450 Infinite Drive, Louisville, Colorado 80027

Phone: (303) 625-2700

Website: http://www.globeimmune.com

Business Description: GlobeImmune, Inc. is a biopharmaceutical company

Investment & Return Details

VC backers: Healthcare Ventures LLC, Lilly Ventures Management Company LLC, Medica Venture Partners, Morgenthaler Ventures, Sequel Venture Partners, Wexford Capital LP

Investment Dates: 06/06/2003, 09/07/2004, 06/03/2005, 09/15/2005, 01/10/2006, 07/09/2007, 05/14/2009, 05/31/2009, 01/19/2010, 03/12/2014

Total Funding To Date (USD Mil): $128.07

Value of VCs’ shares at IPO price (USD Mil): $536.76

Total return to VCs at IPO price: 4.19x

Shares Beneficially owned by VCs at Offering:

  • Healthcare Ventures LLC: 12,655,114
  • Lilly Ventures Management Company LLC: 5,791,812
  • Medica Venture Partners: 5,763,331
  • Morgenthaler Ventures: 12,849,540
  • Sequel Venture Partners: 8,241,698
  • Wexford Capital LP: 8,374,567
  • Total: 53,676,062

Value of VC shares at IPO price (USD Mil):

  • Healthcare Ventures LLC: $126.55
  • Lilly Ventures Management Company LLC: $57.92
  • Medica Venture Partners: $57.63
  • Morgenthaler Ventures: $128.50
  • Sequel Venture Partners: $82.42
  • Wexford Capital LP: $83.75
  • Total: $536.76

IPO Details

Primary Exchange: Nasdaq

Ticker: GBIM

Time to Exit (Years): 11.1

Date Filed: 03/14/2014

Date Issued: 07/01/2014

Offer Price (USD): $10.00

First Day Closing Price (USD): $11.05

No. of Shares Offered + Overallot Sold All Mkts: 1,725,000

Proceeds Amt + Overallot Sold All Markets (USD Mil): $17.25

Post Offer Value (USD Mil): $53.53

Issuer’s Legal Advisor: Cooley LLP

Book Runner: Aegis Capital Corp.

Source: Thomson Reuters and company prospectus